US Stock MarketDetailed Quotes
RLFTF RELIEF THERAPEUTICS HOLDING AG
- 1.382500
- +0.092500+7.17%
15min DelayTrading Jul 16 12:03 ET
17.34MMarket Cap-148P/E (TTM)
1.382500High1.290000Low453Volume1.290000Open1.290000Pre Close608.55Turnover0.01%Turnover RatioLossP/E (Static)12.54MShares4.75000052wk High0.30P/B12.27MFloat Cap1.14000052wk Low--Dividend TTM8.88MShs Float8.060000Historical High--Div YieldTTM7.17%Amplitude0.013700Historical Low1.343000Avg Price1Lot Size
RELIEF THERAPEUTICS HOLDING AG Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | (FY)Dec 31, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 27.00%-17.61M | 32.45%-24.13M | -95.67%-35.72M | -2,407.42%-18.25M | -728K | |||||
| Net income from continuing operations | -93.31%-98.18M | -46.35%-50.79M | -343.34%-34.71M | -4.93%-7.83M | -1,611.01%-7.46M | 84.90%-436K | -17,049.82%-2.89M | 79.22%-16.83K | 99.34%-81K | 0.03%-12.28M |
| Operating gains losses | -902.53%-792K | -118.24%-79K | 118.90%433K | -2,201.83%-2.29M | --109K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -14.04%3.32M | 89.59%3.86M | --2.04M | --0 | --1K | ---- | ---- | ---- | ---- | ---- |
| Deferred tax | -282.96%-13.5M | -330.00%-3.53M | -152.33%-820K | 133.33%1.57M | ---4.7M | --0 | 2,191,011.11%986K | --45 | ---- | -162.35%-146.7K |
| Other non cash items | 42.89%-3.99M | -673.42%-6.99M | 118.46%1.22M | 458.00%558K | 219.05%100K | -150.91%-84K | 50,669.23%165K | --325 | ---- | -68.06%349.91K |
| Change In working capital | -117.72%-991K | 206.84%5.59M | -34,793.33%-5.23M | -140.54%-15K | 123.42%37K | -135.59%-158K | 74,347.49%444K | -101.11%-598 | 102.90%54K | -236.52%-1.86M |
| -Change in receivables | 778.95%129K | 90.87%-19K | ---208K | --0 | ---- | -128.42%-54K | 1,187,600.00%190K | ---16 | ---- | -73.58%1.11M |
| -Change in inventory | -301.22%-330K | 247.75%164K | ---111K | ---- | ---- | ---- | ---- | ---- | ---- | -92.25%3.61K |
| -Change in payables and accrued expense | -138.17%-1.07M | 81.56%-448K | -152.44%-2.43M | 1,724.41%4.63M | --254K | ---- | ---- | ---- | ---- | ---- |
| -Change in other current assets | -102.52%-163K | 350.72%6.48M | 33.27%-2.59M | -10,370.27%-3.87M | ---37K | ---- | ---- | ---- | ---- | 104.88%2.08M |
| -Change in other current liabilities | ---- | ---- | ---- | -3,685.00%-717K | --20K | --0 | ---- | ---32 | ---- | --0 |
| -Change in other working capital | 175.09%440K | -686.00%-586K | 272.41%100K | 71.00%-58K | ---200K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 27.00%-17.61M | 32.45%-24.13M | -95.67%-35.72M | -2,407.42%-18.25M | -17.80%-728K | 47.31%-618K | -40,516.34%-1.17M | 89.30%-2.89K | 99.69%-27K | 0.32%-8.73M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 208.70%8.7M | 73.57%-8M | -1,107.05%-30.26M | 3.01M | ||||||
| Net PPE purchase and sale | -1,251.52%-446K | -400.00%-33K | --11K | --0 | ---- | ---- | ---- | ---11 | ---- | 24.52%-24.05K |
| Net intangibles purchase and sale | 1,955.12%9.05M | 96.44%-488K | ---13.71M | --0 | ---- | ---- | ---- | ---- | ---- | 34.07%-561.53K |
| Net business purchase and sale | --0 | 52.52%-7.92M | -104,156.25%-16.68M | ---16K | ---- | ---- | ---- | --132 | ---- | ---- |
| Net investment purchase and sale | -101.18%-5K | 288.99%424K | -96.66%109K | --3.26M | ---- | ---- | ---- | --4 | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---241K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 208.70%8.7M | 73.57%-8M | -1,107.05%-30.26M | --3.01M | ---- | --0 | --0 | --125 | ---- | 39.13%-585.58K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -36.89%4.05M | -90.52%6.42M | 16.30%67.69M | 9,600.00%58.2M | 600K | |||||
| Net issuance payments of debt | -16.77%-550K | 91.22%-471K | -1,173.20%-5.37M | -16.67%500K | --600K | --0 | ---- | --301 | ---- | ---1.52M |
| Net common stock issuance | -28.36%5.09M | -90.65%7.11M | 30.44%76.09M | --58.33M | ---- | -28.76%748K | 34,046.34%1.05M | --3.08K | ---- | 82.32%14.93M |
| Net other financing activities | -121.52%-494K | 92.17%-223K | -349.21%-2.85M | ---634K | ---- | ---- | ---- | ---- | ---- | -99.46%8.42K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -36.89%4.05M | -90.52%6.42M | 16.30%67.69M | 9,600.00%58.2M | -19.79%600K | -18.16%748K | 28,971.25%914K | --3.14K | ---- | 37.56%13.41M |
| Net cash flow | ||||||||||
| Beginning cash position | -57.02%19.24M | 3.72%44.76M | 31,399.27%43.15M | -48.30%137K | 96.30%265K | -65.74%135K | 3,030,669.23%394K | -99.97%13 | -95.70%40K | 8.51%929.48K |
| Current changes in cash | 81.07%-4.87M | -1,604.27%-25.71M | -96.02%1.71M | 33,655.47%42.95M | -198.46%-128K | 150.19%130K | -68,079.00%-259K | 101.41%381 | -100.66%-27K | 16,590.02%4.09M |
| Effect of exchange rate changes | 1.09%186K | 280.39%184K | -254.55%-102K | --66K | --0 | ---- | ---- | ---- | ---- | -121.80%-14.43K |
| End cash Position | -24.33%14.56M | -57.02%19.24M | 3.72%44.76M | 31,399.27%43.15M | -48.30%137K | 96.30%265K | 34,163.96%135K | -96.97%394 | -99.74%13K | 428.42%5.01M |
| Free cash flow | 26.73%-18.06M | 50.13%-24.65M | -170.77%-49.43M | -2,407.42%-18.25M | -17.80%-728K | 47.31%-618K | -40,362.23%-1.17M | 89.26%-2.9K | 99.72%-27K | 0.54%-9.61M |
| Currency Unit | CHF | CHF | CHF | CHF | CHF | CHF | CHF | CHF | CHF | CHF |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg